Experienced executive with over 20 years of experience in the Medtech sector as CEO, VP and R&D leader in Transseptal Solutions, Expanding orthopedics, Remon Medical Technologies. Holds a B.Sc ,Mechanical engineering from Ben-Gurion University of the Negev
Technology and Product
Brings experience in R&D efforts, project management and team leadership in the medical-device industry.
Holds a B.Sc and M.Sc in biomedical engineering from the Technion, Israeli institute of technology.
Dr. Yair Feld
Founder and CMO
MD.PhD Interventional cardiologist, 15+ years experience. Founder of Corassist, Nephera, Paragate Medical, ProArc, Cuspa and Genegrafts
Chariman of the board
CEO & Managing Partner of NGT3 VC. Led the establishment and investment in more than 50 companies such as Prolor Biotech (sold to OPKO for $480M), Mazor Robotics (sold to Medtronic for $1.6B), ReWalk (NASDAQ: RWLK), Corindus (sold to Siemens Healthcare for $1.1B), and many others.
Ms. Ben-Zur brings over 20 years of experience in the medical device and healthcare industries. Prior to joining NGT, Livnat was the CEO of Corolabs, a deep-lung inhaled therapies, and the General Manager of Regentis Biomaterials, a tissue regeneration company
Manages the finances of NGT portfolio companies with strong leadership.
Involved in fund-raising processes, negotiations and complex transactions.
Scientific Advisory Board
Prof. Rafael Beyar
Former Director General, Rambam Health Care Campus (2006-2019) ,Professor Emeritus, The Bruce and Ruth Rappaport Faculty of Medicine, Technion. Interventional Cardiologist, Rambam
Managing General Partner, Alive Health Tech Fund
Dr. Harindra Wijeysundera
Prof. Felix Mahfoud
Affiliate/Visiting Professor of the Harvard-MIT,Biomedical Engineering, Boston, MA
Prof. Jozef Bartunek
Prof. Giora Weisz